Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38,466,645
-
Total 13F shares
-
9,281,116
-
Share change
-
+5,461,460
-
Total reported value
-
$156,205,098
-
Price per share
-
$16.83
-
Number of holders
-
44
-
Value change
-
+$91,832,529
-
Number of buys
-
30
-
Number of sells
-
8
Institutional Holders of Protara Therapeutics, Inc. - Common Stock (TARA) as of Q3 2020
As of 30 Sep 2020 Protara Therapeutics, Inc. - Common Stock (TARA) had 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,281,116 shares of stock of the company.
Largest 10 holders included Opaleye Management Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Ikarian Capital, LLC, Rock Springs Capital Management LP, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, Cormorant Asset Management, LP, PRICE T ROWE ASSOCIATES INC /MD/, FARALLON CAPITAL MANAGEMENT LLC, and FRANKLIN RESOURCES INC.
This table shows 44 institutional shareholders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.